Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) has scheduled a conference call to discuss its first quarter 2025 financial results on Tuesday, May 6 at 9 a.m. ET. The company will release its detailed results before the market opens on the same day.

The conference call will feature key leadership including CEO Dave Pacitti, interim CFO Jason Pickett, SVP of Strategy and Corporate Development Scott Galovan, and Board Chairman Gary Blackford. Participants can join via phone through an automatic registration system or through manual dialing options.

A simultaneous webcast and presentation will be available through the Investors section of Avanos Medical's website. The replay will be accessible for one week following the call.

ALPHARETTA, Ga., April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.

The conference call will be hosted by Dave Pacitti, chief executive officer, Jason Pickett, interim chief financial officer, Scott Galovan, senior vice president, strategy and corporate development, and Gary Blackford, Avanos board chairman.

To instantly join the conference call by phone, use the following link to register close to the call start time: https://emportal.ink/4gbW8ah. After registering, the system will call you and automatically connect you to the conference call. Alternatively, you may join the call by dialing 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.

A simultaneous webcast of the call and the related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/. The replay will be accessible within two hours of the end of the call and will be available for one week. Alternatively, you may dial 1-646-517-4150 or 1-888-660-6345 and enter passcode 22122 #.

About Avanos Medical, Inc. 
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures, and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-first-quarter-2025-financial-results-302439633.html

SOURCE Avanos Medical

FAQ

When will Avanos Medical (AVNS) release its Q1 2025 earnings?

Avanos Medical will release its Q1 2025 earnings before market opens on Tuesday, May 6, 2025.

How can investors join the Avanos Medical Q1 2025 earnings call?

Investors can join through automatic registration at https://emportal.ink/4gbW8ah, or by dialing 1-646-357-8785 or 1-800-836-8184.

Who will be presenting at the Avanos Medical Q1 2025 earnings call?

The call will feature CEO Dave Pacitti, interim CFO Jason Pickett, SVP Scott Galovan, and Board Chairman Gary Blackford.

Where can I find the replay of AVNS Q1 2025 earnings call?

The replay will be available on Avanos Medical's investor website or by dialing 1-646-517-4150 or 1-888-660-6345 with passcode 22122#.